RK

Rajeev Kumar Jain

Active Director Director DIN 10824028
DIN 10824028 First appointment Oct 2022 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 1 historical roles
Total affiliations 2 Since Oct 2022
Shareholding value •••• Premium profile

About Rajeev Kumar Jain

Data last updated:

Rajeev Kumar Jain is a Director at Synthimed Labs Private Limited (since 2025). The companies operate in Pharma. Synthimed Labs Private Limited reported revenue of ₹1,478 Cr (FY 2025). Earlier, Rajeev Kumar Jain was a Ceo at Supriya Lifescience Limited (2022–2024).

DIN 10824028
Primary Designation Director
Industry Pharma
First Appointment 03 Oct 2022
Oldest Company Age 3 yrs
Largest company Synthimed Labs Private Limited · ₹1,478 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Synthimed Labs Private Limited U21001CH2023PTC045205
Director19 May 20252023₹1,478 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Supriya Lifescience Limited L51900MH2008PLC180452
Ceo03 Oct 20222008₹839 Cr (FY 2026)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Rajeev Kumar Jain

Directorship timeline

Open interactive timeline →
Synthimed Labs Private Limited
Supriya Lifescience Limited
Premium access

Shareholding and investment profile for Rajeev Kumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajeev Kumar Jain

Rajeev Kumar Jain currently holds 1 directorship: Synthimed Labs Private Limited (Director, since 19 May 2025, revenue ₹1,478 Cr (FY 2025)).

Rajeev Kumar Jain was first appointed on 03 Oct 2022 as Ceo at Supriya Lifescience Limited. The most recent appointment on record is 19 May 2025 at Synthimed Labs Private Limited.

Rajeev Kumar Jain held 1 earlier board appointment: Supriya Lifescience Limited (Ceo, 03 Oct 2022 to 14 Jun 2024).

The current boards of Rajeev Kumar Jain's companies include Ashish Poddar (Synthimed Labs Private Limited), Hrishikesh Dinkar Samant (Synthimed Labs Private Limited), Kacharu Shivprasad Toshniwal (Synthimed Labs Private Limited), Kacharu Shivprasad Toshniwal (Synthimed Labs Private Limited), Mrinal Chandran (Synthimed Labs Private Limited), Renu Pandey (Synthimed Labs Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available